Notice of Application to Register a Trade Name Product (Notice No. MPI 454)
Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: Tildren 500mg lyophilisate for solution for infusion
Reference: A11167
Active Ingredient and Concentration:
Tiludronic acid (as disodium tiludronate) 500mg/vial
Formulation Type: Freeze-dried powder for reconstitution with an isotonic solution
General Use Claim:
For the treatment for lameness associated with bone and cartilage changes in horses.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Lee Metcalf, c/o Bell Gully, Level 22, Vero Centre, 48 Shortland Street, Auckland 1010. Postal Address: Lee Metcalf, CEVA Animal Health (NZ) Limited, 11 Moores Road, Glenorie, New South Wales 2157, Australia.
Dated at Wellington this 3rd day of February 2015.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).